Fifth Third Bancorp Global Blood Therapeutics, Inc. Transaction History

Fifth Third Bancorp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	SELL	$48.73 - $81.82 $3,021 - $5,072	-62 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $2,811 - $3,590	62 New	62 $3,000
Q2 2019 Aug 07, 2019	SELL	$52.6 - $63.29 $21,040 - $25,316	-400 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$39.99 - $53.48 $10,157 - $13,583	-254 Reduced 38.84%	400 $21,000
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $8,011 - $11,854	254 Added 63.5%	654 $27,000
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $15,200 - $20,440	400 New	400 $15,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.